These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 36551947)
1. Methylene Blue Delivery Mediated by Focused Ultrasound-Induced Blood-Brain Barrier Disruption Reduces Neural Damage and Amyloid-Beta Plaques by AQP-4 Upregulation. Choi HJ; Han M; Jung B; Hong YR; Shin S; Lim S; Lee EH; Kim YK; Park J Biomedicines; 2022 Dec; 10(12):. PubMed ID: 36551947 [TBL] [Abstract][Full Text] [Related]
2. Focused ultrasound with anti-pGlu3 Aβ enhances efficacy in Alzheimer's disease-like mice via recruitment of peripheral immune cells. Sun T; Shi Q; Zhang Y; Power C; Hoesch C; Antonelli S; Schroeder MK; Caldarone BJ; Taudte N; Schenk M; Hettmann T; Schilling S; McDannold NJ; Lemere CA J Control Release; 2021 Aug; 336():443-456. PubMed ID: 34186148 [TBL] [Abstract][Full Text] [Related]
3. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease. Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247 [TBL] [Abstract][Full Text] [Related]
4. A sporadic Alzheimer's blood-brain barrier model for developing ultrasound-mediated delivery of Aducanumab and anti-Tau antibodies. Wasielewska JM; Chaves JCS; Johnston RL; Milton LA; Hernández D; Chen L; Song J; Lee W; Leinenga G; Nisbet RM; Pébay A; Götz J; White AR; Oikari LE Theranostics; 2022; 12(16):6826-6847. PubMed ID: 36276649 [No Abstract] [Full Text] [Related]
6. The new insight into the inflammatory response following focused ultrasound-mediated blood-brain barrier disruption. Choi HJ; Han M; Seo H; Park CY; Lee EH; Park J Fluids Barriers CNS; 2022 Dec; 19(1):103. PubMed ID: 36564820 [TBL] [Abstract][Full Text] [Related]
7. Focused ultrasound-mediated blood-brain barrier opening in Alzheimer's disease: long-term safety, imaging, and cognitive outcomes. Rezai AR; Ranjan M; Haut MW; Carpenter J; D'Haese PF; Mehta RI; Najib U; Wang P; Claassen DO; Chazen JL; Krishna V; Deib G; Zibly Z; Hodder SL; Wilhelmsen KC; Finomore V; Konrad PE; Kaplitt M; J Neurosurg; 2023 Jul; 139(1):275-283. PubMed ID: 36334289 [TBL] [Abstract][Full Text] [Related]
8. Neutrophil recruitment and leukocyte response following focused ultrasound and microbubble mediated blood-brain barrier treatments. Poon C; Pellow C; Hynynen K Theranostics; 2021; 11(4):1655-1671. PubMed ID: 33408773 [No Abstract] [Full Text] [Related]
10. Utilization of focused ultrasound for opening of the blood-nerve barrier. Umansky D; Bing C; Chu TH; Alzahrani S; Dunn JF; Pichardo S; Midha R Phys Med Biol; 2022 Oct; 67(20):. PubMed ID: 36055246 [No Abstract] [Full Text] [Related]
11. Ultrasound-mediated augmented exosome release from astrocytes alleviates amyloid-β-induced neurotoxicity. Deng Z; Wang J; Xiao Y; Li F; Niu L; Liu X; Meng L; Zheng H Theranostics; 2021; 11(9):4351-4362. PubMed ID: 33754065 [No Abstract] [Full Text] [Related]
12. "Focused Ultrasound-mediated Drug Delivery in Humans - a Path Towards Translation in Neurodegenerative Diseases". Wasielewska JM; White AR Pharm Res; 2022 Mar; 39(3):427-439. PubMed ID: 35257286 [TBL] [Abstract][Full Text] [Related]
13. An advanced focused ultrasound protocol improves the blood-brain barrier permeability and doxorubicin delivery into the rat brain. Jung B; Huh H; Lee EH; Han M; Park J J Control Release; 2019 Dec; 315():55-64. PubMed ID: 31669208 [TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease brain endothelial-like cells reveal differential drug transporter expression and modulation by potentially therapeutic focused ultrasound. Chaves JCS; Wasielewska JM; Cuní-López C; Rantanen LM; Lee S; Koistinaho J; White AR; Oikari LE Neurotherapeutics; 2024 Jan; 21(1):e00299. PubMed ID: 38241156 [TBL] [Abstract][Full Text] [Related]
15. Ultrasound-targeted microbubbles destruction assists dual delivery of beta-amyloid antibody and neural stem cells to restore neural function in transgenic mice of Alzheimer's disease. Zhu Q; Xu X; Chen B; Liao Y; Guan X; He Y; Cui H; Rong Y; Liu Z; Xu Y Med Phys; 2022 Mar; 49(3):1357-1367. PubMed ID: 35092698 [TBL] [Abstract][Full Text] [Related]
16. Enhanced delivery of a low dose of aducanumab via FUS in 5×FAD mice, an AD model. Kong C; Yang EJ; Shin J; Park J; Kim SH; Park SW; Chang WS; Lee CH; Kim H; Kim HS; Chang JW Transl Neurodegener; 2022 Dec; 11(1):57. PubMed ID: 36575534 [TBL] [Abstract][Full Text] [Related]
17. [Focused ultrasound as a non-invasive method with therapeutic potential in patients with Alzheimer's disease]. Kovalenko EA; Makhnovich EV; Osinovskaya NA; Bogolepova AN Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(10):38-45. PubMed ID: 36279227 [TBL] [Abstract][Full Text] [Related]
19. Localized Modification of Water Molecule Transport After Focused Ultrasound-Induced Blood-Brain Barrier Disruption in Rat Brain. Han M; Seo H; Choi H; Lee EH; Park J Front Neurosci; 2021; 15():685977. PubMed ID: 34393708 [TBL] [Abstract][Full Text] [Related]
20. The Applications of Focused Ultrasound (FUS) in Alzheimer's Disease Treatment: A Systematic Review on Both Animal and Human Studies. Liu X; Naomi SSM; Sharon WL; Russell EJ Aging Dis; 2021 Dec; 12(8):1977-2002. PubMed ID: 34881081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]